There is convincing evidence that PD-L1 promotes HNSCC cell growth through mTOR signaling, further supporting the role of mTOR metabolic signaling in immune evasion in HNSCC (58). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.